DAY ONE BIOPHARMACEUTICALS ($DAWN) is expected to release its quarterly earnings data on Tuesday, July 8th before market open, per Finnhub. Analysts are expecting revenue of $36,644,907 and earnings of -$0.36 per share.
You can see Quiver Quantitative's $DAWN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DAY ONE BIOPHARMACEUTICALS Insider Trading Activity
DAY ONE BIOPHARMACEUTICALS insiders have traded $DAWN stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $DAWN stock by insiders over the last 6 months:
- JEREMY BENDER (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 2 sales selling 26,012 shares for an estimated $231,515.
- ADAM DUBOW (GENERAL COUNSEL) has made 0 purchases and 2 sales selling 9,198 shares for an estimated $84,066.
- CHARLES N II YORK (COO, CFO AND SECRETARY) has made 0 purchases and 2 sales selling 8,652 shares for an estimated $79,074.
- LAUREN MERENDINO (Chief Commercial Officer) sold 3,927 shares for an estimated $24,574
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DAY ONE BIOPHARMACEUTICALS Hedge Fund Activity
We have seen 106 institutional investors add shares of DAY ONE BIOPHARMACEUTICALS stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FAIRMOUNT FUNDS MANAGEMENT LLC removed 3,103,448 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $24,610,342
- POLAR CAPITAL HOLDINGS PLC added 2,165,000 shares (+1170.3%) to their portfolio in Q1 2025, for an estimated $17,168,450
- TIMESSQUARE CAPITAL MANAGEMENT, LLC removed 1,710,926 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $13,567,643
- ALYESKA INVESTMENT GROUP, L.P. added 1,547,577 shares (+61.6%) to their portfolio in Q1 2025, for an estimated $12,272,285
- BRAIDWELL LP removed 1,337,000 shares (-27.4%) from their portfolio in Q1 2025, for an estimated $10,602,410
- JANUS HENDERSON GROUP PLC removed 1,284,920 shares (-98.4%) from their portfolio in Q1 2025, for an estimated $10,189,415
- VESTAL POINT CAPITAL, LP added 1,158,127 shares (+80.4%) to their portfolio in Q1 2025, for an estimated $9,183,947
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
